Last 12 months
Inside the activity.
0 purchase rows · 36 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 17 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 03, 2023 Filed Jul 5, 2023 20:05 UTC |
Azoy AlexanderChief Accounting Officer
|
SaleCommon Stock | 1,018 | $20.41 | $20,777.38 |
DisclosureSEC source: 0001209191-23-040964 · doc4.xml · nonDerivative · entry 1 Azoy Alexander · CIK 0001771961 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,596 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 30, 2023. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 19:12 UTC |
GILEAD SCIENCES, INC.10% owner
|
PurchaseCommon Stock | 1,010,000 | $19.26 | $19,452,600.00 |
DisclosureSEC source: 0001104659-23-077015 · tm2320354-1_4seq1.xml · nonDerivative · entry 1 GILEAD SCIENCES, INC. · CIK 0000882095 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,823,029 Read SEC document |
| June 22, 2023 Filed Jun 26, 2023 20:36 UTC |
Jarrett JenniferDirector · Chief Operating Officer
|
SaleCommon Stock | 12,437 | $19.12 | $237,795.44 |
DisclosureSEC source: 0001209191-23-039718 · doc4.xml · nonDerivative · entry 1 Jarrett Jennifer · CIK 0001671311 · Director · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 381,566 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2023. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.78 to $19.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 16, 2023 Filed Jun 16, 2023 20:17 UTC |
Tang Carolyn C.General Counsel
|
Disposition to issuerCommon Stock | 2,892 | $19.35 | $55,960.20 |
DisclosureSEC source: 0001209191-23-038160 · doc4.xml · nonDerivative · entry 1 Tang Carolyn C. · CIK 0001836662 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,902 F1 · shares: Represents shares sold by the Issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on January 15, 2021, and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.86 to $19.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes 1,255 shares purchased on 5/31/2023 through the Company's Employee Stock Purchase Plan. Read SEC document |
| June 16, 2023 Filed Jun 17, 2023 00:16 UTC |
Jarrett JenniferDirector · Chief Operating Officer
|
SaleCommon Stock | 12,563 | $19.35 | $243,094.05 |
DisclosureSEC source: 0001209191-23-038157 · doc4.xml · nonDerivative · entry 1 Jarrett Jennifer · CIK 0001671311 · Director · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 394,003 F1 · shares: Represents shares sold by the Issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on January 15, 2021, and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.86 to $19.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes 349 shares purchased on 5/31/2023 through the Company's Employee Stock Purchase Plan. Read SEC document |
| June 16, 2023 Filed Jun 17, 2023 00:14 UTC |
Jaen Juan C.Director · President
|
Disposition to issuerCommon Stock | 4,820 | $19.35 | $93,267.00 |
DisclosureSEC source: 0001209191-23-038154 · doc4.xml · nonDerivative · entry 2 Jaen Juan C. · CIK 0001422996 · Director · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 313,862 F2 · shares: Represents shares sold by the Issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on January 15, 2021, and does not represent a discretionary trade by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.86 to $19.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 16, 2023 Filed Jun 17, 2023 00:12 UTC |
ROSEN TERRY JDirector · Chief Executive Officer
|
Disposition to issuerCommon Stock | 8,762 | $19.35 | $169,544.70 |
DisclosureSEC source: 0001209191-23-038152 · doc4.xml · nonDerivative · entry 1 ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,894,231 F1 · shares: Represents shares sold by the Issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on January 15, 2021, and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.86 to $19.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes 3,433,870 shares that were previously indirectly held by the reporting person through The Rosen Family Trust. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:14 UTC |
Jaen Juan C.Director · President
|
GiftCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038154 · doc4.xml · nonDerivative · entry 1 Jaen Juan C. · CIK 0001422996 · Director · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 318,682 F1 · kind: Represents a gift to a family trust over which the reporting person has neither voting nor investment control. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:11 UTC |
Lambert NicoleDirector
|
GrantStock Option (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $19.60 | $0.00 |
DisclosureSEC source: 0001209191-23-038150 · doc4.xml · derivative · entry 2 Lambert Nicole · CIK 0001770252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2033-06-14 F2 · derivative.exercise_date: The option will vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The option becomes fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:11 UTC |
Lambert NicoleDirector
|
GrantCommon Stock | 6,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038150 · doc4.xml · nonDerivative · entry 1 Lambert Nicole · CIK 0001770252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,600 F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:09 UTC |
PERLMAN ANDREW JDirector
|
GrantStock Option (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $19.60 | $0.00 |
DisclosureSEC source: 0001209191-23-038148 · doc4.xml · derivative · entry 2 PERLMAN ANDREW J · CIK 0001201617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2033-06-14 F2 · derivative.exercise_date: The option will vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:09 UTC |
PERLMAN ANDREW JDirector
|
GrantCommon Stock | 6,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038148 · doc4.xml · nonDerivative · entry 1 PERLMAN ANDREW J · CIK 0001201617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,925 F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:08 UTC |
Lacey David L.Director
|
GrantStock Option (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $19.60 | $0.00 |
DisclosureSEC source: 0001209191-23-038145 · doc4.xml · derivative · entry 2 Lacey David L. · CIK 0001734422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2033-06-14 F2 · derivative.exercise_date: The option will vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:08 UTC |
Lacey David L.Director
|
GrantCommon Stock | 6,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038145 · doc4.xml · nonDerivative · entry 1 Lacey David L. · CIK 0001734422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,252 F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:06 UTC |
Ribas AntoniDirector
|
GrantStock Option (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $19.60 | $0.00 |
DisclosureSEC source: 0001209191-23-038144 · doc4.xml · derivative · entry 3 Ribas Antoni · CIK 0001792164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2033-06-14 F2 · derivative.exercise_date: The option will vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:06 UTC |
Ribas AntoniDirector
|
GrantCommon Stock | 6,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038144 · doc4.xml · nonDerivative · entry 1 Ribas Antoni · CIK 0001792164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,950 F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:05 UTC |
Machado PatrickDirector
|
GrantStock Option (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $19.60 | $0.00 |
DisclosureSEC source: 0001209191-23-038142 · doc4.xml · derivative · entry 2 Machado Patrick · CIK 0001311210 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2033-06-14 F2 · derivative.exercise_date: The option will vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:05 UTC |
Machado PatrickDirector
|
GrantCommon Stock | 6,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038142 · doc4.xml · nonDerivative · entry 1 Machado Patrick · CIK 0001311210 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,900 F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:03 UTC |
KANEKO YASUNORIDirector
|
GrantStock Option (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $19.60 | $0.00 |
DisclosureSEC source: 0001209191-23-038141 · doc4.xml · derivative · entry 5 KANEKO YASUNORI · CIK 0001277503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2033-06-14 F3 · derivative.exercise_date: The option will vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:03 UTC |
KANEKO YASUNORIDirector
|
GrantCommon Stock | 6,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038141 · doc4.xml · nonDerivative · entry 1 KANEKO YASUNORI · CIK 0001277503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,800 F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:01 UTC |
FALBERG KATHRYN EDirector
|
GrantStock Option (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $19.60 | $0.00 |
DisclosureSEC source: 0001209191-23-038139 · doc4.xml · derivative · entry 4 FALBERG KATHRYN E · CIK 0001206977 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2033-06-14 F3 · derivative.exercise_date: The option will vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The option becomes fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:01 UTC |
FALBERG KATHRYN EDirector
|
GrantCommon Stock | 6,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038139 · doc4.xml · nonDerivative · entry 2 FALBERG KATHRYN E · CIK 0001206977 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,900 F2 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:01 UTC |
FALBERG KATHRYN EDirector
|
GiftCommon Stock | 50,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038139 · doc4.xml · nonDerivative · entry 1 FALBERG KATHRYN E · CIK 0001206977 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,100 F1 · kind: Represents a gift to a family member. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:05 UTC |
Goeltz II Robert C.Chief Financial Officer
|
SaleCommon Stock | 4,049 | $20.04 | $81,141.96 |
DisclosureSEC source: 0001209191-23-035740 · doc4.xml · nonDerivative · entry 1 Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,392 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2023. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 16, 2023 Filed Mar 20, 2023 20:12 UTC |
Jarrett JenniferDirector · Chief Operating Officer
|
SaleCommon Stock | 8,729 | $16.81 | $146,734.49 |
DisclosureSEC source: 0001209191-23-020037 · doc4.xml · nonDerivative · entry 1 Jarrett Jennifer · CIK 0001671311 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 406,217 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.66 to $16.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 22:04 UTC |
Jarrett JenniferDirector · Chief Operating Officer
|
SaleCommon Stock | 1,600 | $23.52 | $37,632.00 |
DisclosureSEC source: 0001209191-23-005513 · doc4.xml · nonDerivative · entry 2 Jarrett Jennifer · CIK 0001671311 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,946 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.50 to $23.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 26, 2023 Filed Jan 30, 2023 22:04 UTC |
Jarrett JenniferDirector · Chief Operating Officer
|
SaleCommon Stock | 300 | $23.56 | $7,068.00 |
DisclosureSEC source: 0001209191-23-005513 · doc4.xml · nonDerivative · entry 1 Jarrett Jennifer · CIK 0001671311 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,546 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.50 to $23.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 17:52 UTC |
Tang Carolyn C.General Counsel
|
GrantStock Option (right to buy) · Derivative | 138,200 | $0.00 Strike: $22.02 | $0.00 |
DisclosureSEC source: 0001209191-23-004874 · doc4.xml · derivative · entry 2 Tang Carolyn C. · CIK 0001836662 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,200 Underlying: Common Stock · 138,200 shares Expires 2033-01-22 F2 · derivative.exercise_date: The option becomes exercisable in 48 equal monthly installments after January 1, 2023, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 17:52 UTC |
Tang Carolyn C.General Counsel
|
GrantCommon Stock | 34,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004874 · doc4.xml · nonDerivative · entry 1 Tang Carolyn C. · CIK 0001836662 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,539 F1 · shares: Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2023, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:55 UTC |
Nuyten Dimitry SAChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 138,200 | $0.00 Strike: $22.02 | $0.00 |
DisclosureSEC source: 0001209191-23-004876 · doc4.xml · derivative · entry 2 Nuyten Dimitry SA · CIK 0001776564 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,200 Underlying: Common Stock · 138,200 shares Expires 2033-01-22 F2 · derivative.exercise_date: The option becomes exercisable in 48 equal monthly installments after January 1, 2023, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:55 UTC |
Nuyten Dimitry SAChief Medical Officer
|
GrantCommon Stock | 34,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004876 · doc4.xml · nonDerivative · entry 1 Nuyten Dimitry SA · CIK 0001776564 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,500 F1 · shares: Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2023, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:53 UTC |
Goeltz II Robert C.Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 138,200 | $0.00 Strike: $22.02 | $0.00 |
DisclosureSEC source: 0001209191-23-004875 · doc4.xml · derivative · entry 2 Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,200 Underlying: Common Stock · 138,200 shares Expires 2033-01-22 F2 · derivative.exercise_date: The option becomes exercisable in 48 equal monthly installments after January 1, 2023, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:53 UTC |
Goeltz II Robert C.Chief Financial Officer
|
GrantCommon Stock | 34,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004875 · doc4.xml · nonDerivative · entry 1 Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,441 F1 · shares: Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2023, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:51 UTC |
Jarrett JenniferDirector · Chief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 185,900 | $0.00 Strike: $22.02 | $0.00 |
DisclosureSEC source: 0001209191-23-004873 · doc4.xml · derivative · entry 2 Jarrett Jennifer · CIK 0001671311 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,900 Underlying: Common Stock · 185,900 shares Expires 2033-01-22 F2 · derivative.exercise_date: The option becomes exercisable in 48 equal monthly installments after January 1, 2023, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:51 UTC |
Jarrett JenniferDirector · Chief Operating Officer
|
GrantCommon Stock | 45,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004873 · doc4.xml · nonDerivative · entry 1 Jarrett Jennifer · CIK 0001671311 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,846 F1 · shares: Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2023, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:50 UTC |
Jaen Juan C.Director · President
|
GrantStock Option (right to buy) · Derivative | 185,900 | $0.00 Strike: $22.02 | $0.00 |
DisclosureSEC source: 0001209191-23-004872 · doc4.xml · derivative · entry 3 Jaen Juan C. · CIK 0001422996 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,900 Underlying: Common Stock · 185,900 shares Expires 2033-01-22 F2 · derivative.exercise_date: The option becomes exercisable in 48 equal monthly installments after January 1, 2023, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:50 UTC |
Jaen Juan C.Director · President
|
GrantCommon Stock | 45,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004872 · doc4.xml · nonDerivative · entry 1 Jaen Juan C. · CIK 0001422996 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,682 F1 · shares: Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2023, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:49 UTC |
ROSEN TERRY JDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 429,000 | $0.00 Strike: $22.02 | $0.00 |
DisclosureSEC source: 0001209191-23-004870 · doc4.xml · derivative · entry 3 ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 429,000 Underlying: Common Stock · 429,000 shares Expires 2033-01-22 F2 · derivative.exercise_date: The option becomes exercisable in 48 equal monthly installments after January 1, 2023, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:49 UTC |
ROSEN TERRY JDirector · Chief Executive Officer
|
GrantCommon Stock | 105,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004870 · doc4.xml · nonDerivative · entry 1 ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 469,123 F1 · shares: Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2023, subject to the Reporting Person's continued service to the Company. Read SEC document |
| December 16, 2022 Filed Dec 16, 2022 21:42 UTC |
Tang Carolyn C.General Counsel
|
SaleCommon Stock | 398 | $31.23 | $12,429.54 |
DisclosureSEC source: 0001209191-22-061761 · doc4.xml · nonDerivative · entry 2 Tang Carolyn C. · CIK 0001836662 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,584 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.05 to $31.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 16, 2022 Filed Dec 16, 2022 21:42 UTC |
Tang Carolyn C.General Counsel
|
SaleCommon Stock | 2,125 | $30.66 | $65,152.50 |
DisclosureSEC source: 0001209191-22-061761 · doc4.xml · nonDerivative · entry 1 Tang Carolyn C. · CIK 0001836662 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,982 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.05 to $31.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 16, 2022 Filed Dec 17, 2022 02:44 UTC |
Goeltz II Robert C.Chief Financial Officer
|
SaleCommon Stock | 387 | $31.23 | $12,086.01 |
DisclosureSEC source: 0001209191-22-061762 · doc4.xml · nonDerivative · entry 2 Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,566 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.05 to $31.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 16, 2022 Filed Dec 17, 2022 02:44 UTC |
Goeltz II Robert C.Chief Financial Officer
|
SaleCommon Stock | 2,066 | $30.66 | $63,343.56 |
DisclosureSEC source: 0001209191-22-061762 · doc4.xml · nonDerivative · entry 1 Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,953 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.05 to $31.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 16, 2022 Filed Dec 17, 2022 02:40 UTC |
Jaen Juan C.Director · President
|
SaleCommon Stock | 701 | $31.23 | $21,892.23 |
DisclosureSEC source: 0001209191-22-061759 · doc4.xml · nonDerivative · entry 2 Jaen Juan C. · CIK 0001422996 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,258 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.05 to $31.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 16, 2022 Filed Dec 17, 2022 02:40 UTC |
Jaen Juan C.Director · President
|
SaleCommon Stock | 3,735 | $30.66 | $114,515.10 |
DisclosureSEC source: 0001209191-22-061759 · doc4.xml · nonDerivative · entry 1 Jaen Juan C. · CIK 0001422996 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,959 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.05 to $31.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 16, 2022 Filed Dec 17, 2022 02:39 UTC |
ROSEN TERRY JDirector · Chief Executive Officer
|
SaleCommon Stock | 2,060 | $31.23 | $64,333.80 |
DisclosureSEC source: 0001209191-22-061758 · doc4.xml · nonDerivative · entry 2 ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,173 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.05 to $31.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 16, 2022 Filed Dec 17, 2022 02:39 UTC |
ROSEN TERRY JDirector · Chief Executive Officer
|
SaleCommon Stock | 10,983 | $30.66 | $336,738.78 |
DisclosureSEC source: 0001209191-22-061758 · doc4.xml · nonDerivative · entry 1 ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,233 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.05 to $31.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 16, 2022 Filed Dec 17, 2022 02:41 UTC |
Jarrett JenniferDirector · Chief Operating Officer
|
SaleCommon Stock | 2,603 | $31.23 | $81,291.69 |
DisclosureSEC source: 0001209191-22-061760 · doc4.xml · nonDerivative · entry 2 Jarrett Jennifer · CIK 0001671311 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,609 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.05 to $31.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 16, 2022 Filed Dec 17, 2022 02:41 UTC |
Jarrett JenniferDirector · Chief Operating Officer
|
SaleCommon Stock | 13,879 | $30.66 | $425,530.14 |
DisclosureSEC source: 0001209191-22-061760 · doc4.xml · nonDerivative · entry 1 Jarrett Jennifer · CIK 0001671311 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,212 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.05 to $31.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes 336 shares purchased on 11/30/2022 through the Company's Employee Stock Purchase Plan. Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 20:08 UTC |
Jarrett JenniferDirector · Chief Operating Officer
|
SaleCommon Stock | 12,677 | $26.28 | $333,151.56 |
DisclosureSEC source: 0001209191-22-050704 · doc4.xml · nonDerivative · entry 1 Jarrett Jennifer · CIK 0001671311 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,942 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.89 to $26.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.